Answers are grounded in this paper and cite their sources.
A patient with stage IV non-Hodgkin's lymphoma and chronic hepatitis who was treated with chemotherapy and rituximab developed fatal reactivation of hepatitis B. High viral load titers of hepatitis B DNA were demonstrated. DNA sequencing analysis revealed the presence of the precore mutant strain. Hepatitis B reactivation in patients receiving rituxmab-based chemotherapy is reviewed and the role of precore mutant virus strains resulting in fatal complications is discussed.
No takes yet. Share an insight, caveat, or question.
Zell et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: